Company Name: |
3B Pharmachem (Wuhan) International Co.,Ltd.
|
Tel: |
821-50328103-801 18930552037 |
Email: |
3bsc@sina.com |
Products Intro: |
Product Name:Naloxone benzoylhydrazone;[(5α)-4,5-Epoxy-3,14-dihydroxy-17-(2-propenyl)Morphinan-6-ylidene]benzoicacidhydrazide CAS:119630-94-3 Purity:99% HPLC Package:1Mg ; 5Mg;10Mg ;100Mg;250Mg ;500Mg ;1g;2.5g ;5g ;10g
|
Company Name: |
EMMX Biotechnology LLC
|
Tel: |
888-539-0666 |
Email: |
info@emmx.com |
Products Intro: |
Product Name:Naloxone benzoylhydrazone CAS:119630-94-3 Purity:98% HPLC Package:5mg;10mg;25mg;50mg;100mg;250mg;500mg;1g
|
Company Name: |
cjbscvictory
|
Tel: |
13348960310 13348960310 |
Email: |
3003867561@qq.com |
Products Intro: |
Product Name:Naloxone benzoylhydrazone CAS:119630-94-3 Purity:98% Package:5mg;10mg;20mg;50mg;100mg;200mg
|
|
| NALOXONE BENZOYLHYDRAZONE Basic information |
Product Name: | NALOXONE BENZOYLHYDRAZONE | Synonyms: | NALOXONE BENZOLYHYDRAZONE K3 OPIOID RECE PTOR AG;[(5α)-4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-ylidene]hydrazide benzoic acid;[(5alpha)-4,5-Epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-yliden]benzoic acid hydrazide;[(5α)-4,5-Epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-ylidene]benzoicacidhydrazide;NalBzoH;Benzoic acid, 2-[(5α)-4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-ylidene]hydrazide;Adamantane Impurity 48;Benzoic acid, 2-[(5α)-4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-ylidene]hydrazide | CAS: | 119630-94-3 | MF: | C26H27N3O4 | MW: | 445.51 | EINECS: | | Product Categories: | Opioid receptor and opioid-like receptor | Mol File: | 119630-94-3.mol | |
| NALOXONE BENZOYLHYDRAZONE Chemical Properties |
density | 1.44±0.1 g/cm3(Predicted) | storage temp. | −20°C | solubility | DMSO: soluble | form | solid | pka | 9.11±0.40(Predicted) | color | yellow |
| NALOXONE BENZOYLHYDRAZONE Usage And Synthesis |
Biological Activity | Mixed opioid receptor agonist/antagonist. Acts as a potent and full agonist at κ , and a partial agonist at μ and δ opioid receptors (pEC 50 values are 9.45, 8.74 and 8.61 in a cAMP assay, 9.70, 8.59 and 8.49 in a [ 35 S]GTP γ S binding assay respectively). Fails to exert agonist effects at NOP receptors and antagonizes agonist-induced NOP activation. Stimulates κ -, μ - and δ -mediated analgesia and blocks NOP-induced supraspinal nociception. |
| NALOXONE BENZOYLHYDRAZONE Preparation Products And Raw materials |
|